Vac­citech makes short move to new head­quar­ters; En­ter­o­Bi­otix rais­es more than $21M in Se­ries A

Ox­ford biotech Vac­citech is mov­ing head­quar­ters — but on­ly about 20 min­utes away.

Vac­citech signed a lease for 31,000 square feet with­in the Zeus de­vel­op­ment at Har­well Sci­ence and In­no­va­tion Cam­pus. The firm plans to re­lo­cate its head­quar­ters there next spring from its cur­rent head­quar­ters in Ox­ford. The length of the lease was not dis­closed.

The com­pa­ny’s op­er­a­tions will be tak­ing about half the space in that build­ing, ac­cord­ing to a Vac­citech state­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER